MYOC and glaucoma: In order to confirm the protective effect and functionally evaluate this finding, we employed a distinct mouse model of glaucoma that is reliant upon adenoviral-mediated expression of a pathogenic variant of human myocilin in the trabecular meshwork of mice [29,30,44].